Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

GTBP GT Biopharma Inc

3,2284

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:00:00

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

GT Biopharma (NASDAQ:GTBP)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more GT Biopharma Charts.

GT Biopharma (NASDAQ:GTBP)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more GT Biopharma Charts.

News GT Biopharma Inc

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 21 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 4 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 6 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 6 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Montag 6 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 1 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Freitag 27 Oktober 2023 (6 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dienstag 19 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 22 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 16 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Weitere GT Biopharma Inc News-Artikel

Euro vs Sterling

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen